Brief: Sensorion FY Net Loss Narrows To 12.1 Million Euros

Sensorion SA

02/04/2020 06:44

April 2 (Reuters) - Sensorion SA  ALSEN.PA :
    * FY NET LOSS -12.1 MILLION EUR
    * CASH POSITION WAS EUR 30.4M AT END OF 2019 WITH A RUNWAY
EXTENDED UNTIL BEGINNING OF Q3 2021 TO ADAPT TO CURRENT
ENVIRONMENT
    * PHII TRIAL WITH SENS-401 IN SSNHL STARTED, IT WILL INCLUDE
PATIENTS FROM FRENCH ARMED FORCES; SENS-401 RECEIVED AN IND IN
US
    * FY NET LOSS EUR 12.1 MILLION VERSUS LOSS EUR 12.4 MILLION
YEAR
AGO
    * FY OPERATING LOSS EUR 10.8 MILLION VERSUS LOSS EUR 12.2
MILLION
YEAR AGO
    * FY IFRS OPERATING REVENUE EUR 2.5 MILLION VERSUS EUR 2.3
MILLION
YEAR AGO
    * ACTIONS HAVE BEEN TAKEN TO SAVE COSTS AND EXTEND CASH
RUNWAY
WHICH IS NOW UNTIL BEGINNING OF Q3 2021
    * ON CORONAVIRUS : DIFFICULT TO DETERMINE EVOLUTION OF
EPIDEMIC
SITUATION BUT THERE IS A RISK THAT IT MIGHT CAUSE DELAY IN
REALIZATION OF PRECLINICAL GENE THERAPY STUDIES
    * RESULTS FROM PHASE 2 OF SENS-401 IN SUDDEN SENSORINEURAL
HEARING
LOSS ARE EXPECTED BY MID-YEAR 2021

Source text for Eikon:  ID:nBw2tSfqva 
Further company coverage:  ALSEN.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))